Articles On Neuren Pharmaceuticals (ASX:NEU)

Plenty of new ASX ETFs have hit the market over the past year.  ETF providers are giving investors more and more opportunities to gain exposure to niche themes and sectors.  Thematic investing involved targeting a specific theme. The...

Highlights Australian equities closed lower amid materials and resources sector movement. ASX 200 session reflected varied performance across healthcare and consumer stocks. Index participation highlights diversified sector...

It has been a tough week for Neuren Pharmaceuticals Ltd (ASX: NEU) shares. Since this time last week, the ASX 200 healthcare stock is down 20%. Is this a buying opportunity? Let's see what Bell Potter is saying about the pharmaceuticals com...

The S&P/ASX 200 Index (ASX: XJO) is having a subdued session on Thursday. In afternoon trade, the benchmark index is down 0.5% to 8,882.3 points. Four ASX shares that are falling more than most today are listed below. Here's why they a...

Highlights Energy and resources regain attention amid shifting global cues Healthcare innovation and commodities drive sector narratives Broader market sentiment reflects selective confidence, not momentum Australian e...

The Neuren Pharmaceuticals Ltd (ASX: NEU) share price has declined more than 8% after giving US updates. Neuren Pharmaceuticals aims to develop new drug therapies to treat multiple serious neurological disorders that emerge in early childho...

Neuren Pharmaceuticals Ltd (ASX: NEU) shares have returned from their trading halt and are deep in the red. In morning trade, the ASX 200 pharma stock is down 9% to $13.30. Why is this ASX 200 stock sinking? Investors have been selling the...

The Champion Iron Ltd (ASX: CIA) share price is in focus today after the company announced a US$100 million private placement to fund its planned acquisition of Rana Gruber. The deal will see La Caisse de dépôt et placement du Québec tak...

The Elders Ltd (ASX: ELD) share price is in focus today after the company announced René Dedoncker will succeed Mark Allison as CEO from 1 October 2026. The Board highlighted Mr Dedoncker's deep agricultural expertise and track record in o...

The Beach Energy Ltd (ASX: BPT) share price is in focus today after the oil and gas producer reported a 32% drop in statutory net profit after tax to $150.2 million for the six months to 31 December 2025. Revenue slipped 1% to $981.7 millio...

ASX today – Australian shares will open (a little) lower this morning, with futures now suggesting we’re heading for a 5-10pt drop, and that may very well turn even flatter as we get closer to the 10am bell today, too. Listen to the HotC...

On Wednesday, the S&P/ASX 200 Index (ASX: XJO) pushed higher thanks to the banks and miners. The benchmark index rose 0.8% to 8,927.8 points. Will the market be able to build on this on Thursday? Here are five things to watch: ASX 200...

Yesterday afternoon, Neuren Pharmaceuticals Ltd (ASX: NEU) shared feedback from recent US FDA meetings on its NNZ-2591 clinical programs. Neuren said it received constructive guidance for its development plans in hypoxic ischemic encephalop...

When people talk about retiring early, it often sounds unrealistic or reserved for high earners. I don't see it that way. For anyone starting in their 20s or 30s, ASX dividend shares offer a very practical path to building a portfolio that...

The S&P/ASX 200 Index (ASX: XJO) and many ASX shares enjoyed another strong session this Wednesday, building on the momentum we saw yesterday to push the share market decisively higher. Despite opening...

ASX builds on yesterday’s gains to add 70 points or 0.8% Weak breadth with seven sectors lower and 110 ASX 200 stocks falling Materials, energy and major banks power gains   Volatile, much? The metals market has been about as predictable...

A pair of ASX-listed property trusts is trading lower on Wednesday after releasing their latest half-year results, despite steady performances. Centuria Office REIT (ASX: COF) shares are down 0.47% to $1.055, while Charter Hall Social I...

With more than seven million users on the HotCopper forums, every discussion and speculation can move Australian markets, which is why getting out in front of those trends is so important for any trader worth their salt. In this daily HotCo...

The Neuren Pharmaceuticals Ltd (ASX: NEU) share price was paused from trading today, with investors awaiting further updates from the company. What did Neuren Pharmaceuticals report? Trading in Neuren Pharmaceuticals shares has been tempor...

Shares in New Zealand-based dairy company Synlait Milk Ltd (ASX: SM1) are trading sharply lower after the company said it would swing to a net loss after a "disappointing" first half. The company said in a statement to the ASX on Wednes...

The Amcor PLC (ASX: AMC) share price is in focus after the packaging giant posted a 68% rise in quarterly net sales to US$5.45 billion, thanks largely to the Berry acquisition. Adjusted EBITDA soared 83% from last year, reaching US$826 mill...

The Abacus Storage King (ASX: ASK) share price is in focus today after the company announced it has started talks to potentially bring its management in-house. Key highlights include the formation of an independent board committee and early...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin US markets recovered in afternoon trade off intraday lows, with gold and silver cont...

During earnings season, it's not uncommon to see large share price swings as investors react to results. Unfortunately for two ASX healthcare shares, recent announcements sent their share prices tumbling.  Neuren Pharmaceuticals Ltd (AS...

Highlights Australian equities closed with measured participation across sectors. ASX 200 activity aligned with broader monetary system developments. Market structure reflected diversified index representation. Austral...

Highlights Market sentiment steadied as global cues improved Resources and technology shares regained momentum Central bank focus shaped cautious positioning Australian shares regained balance as technology and resourc...

highlights Market sentiment lifted ahead of a pivotal policy moment Resources and financials set contrasting tones across sectors Global policy and social trends quietly shaped local confidence Australian equities edge...

With more than seven million users on the HotCopper forums, every discussion and speculation can move Australian markets, which is why getting out in front of those trends is so important for any trader worth their salt. In this daily HotCo...

Neuren Pharmaceuticals Ltd (ASX: NEU) shares are having a tough time on Tuesday. In morning trade, the ASX 200 healthcare share was down as much as 22% to $12.66. The pharmaceuticals company's shares have recovered a touch since then but re...

Highlights Australian health companies reported progress across diagnostics, therapeutics, and clinical development Research milestones and regulatory updates shaped quarterly activity in the healthcare space ASX-listed heal...

The a2 Milk Company Ltd (ASX: A2M) shares have fallen 11% after the company responded to an ASX price query, confirming no undisclosed material information. Management pointed to an external market announcement as a context for the volatili...

The Region Group Ltd (ASX: RGN) share price is in focus today after the company announced a leadership transition, naming Greg Chubb as its new Chief Executive Officer and Managing Director, starting 9 March 2026. Outgoing CEO Anthony Mello...

The A2 Milk Company Ltd (ASX: A2M) share price has been temporarily paused on the ASX pending a further announcement. Investors are watching closely after the company's latest trading halt was declared today. What did The A2 Milk Company re...

The Nickel Industries Ltd (ASX: NIC) share price is in focus today after the miner reported December quarter adjusted EBITDA from operations is expected to be between US$35 million and US$40 million, with record quarterly earnings from its...

The Neuren Pharmaceuticals Ltd (ASX: NEU) share price is in focus following the release of new guidance, with DAYBUE global net sales now projected to reach around US$700 million in 2028. The company highlighted that these royalties and mil...

Shares in ALS Ltd (ASX: ALQ) finished last week on a strong note, closing up 1.88% at $23.86. Earlier in Friday's session, the ALS share price also hit a fresh all-time high of $23.91, marking another milestone in what has been an impres...

ASX health sector up 0.96% for the week, while broader market rises 2% Imricor surges after receiving FDA 510(k) clearance for its Vision MR Diagnostic Catheter Morgans upgrades 12-month target price for EBR systems after strong Q4 CY25 re...

Highlights Global banking and technology trends set the tone for local trade Mining and utilities reflect mixed sentiment across sectors Corporate updates offer insight into operational strategies The ASX session unfol...

Healthcare was the worst performer of the 11 market sectors in 2025, with the S&P/ASX 200 Healthcare Index (ASX: XHJ) falling 24.91%. The typically small dividend paid by healthcare shares offset this only slightly, with the sector's...

The S&P/ASX 200 Index (ASX: XJO) enjoyed another green day this Wednesday, its third of the week, as investors gained optimism about the state of the markets. By the time trading wrapped up today, the A...

Good Afternoon and welcome to HotCopper’s Market Close for Wednesday, I’m Jon Davidson. Yesterday I noted the energy sector led laggards despite higher oil prices, well today the market woke up. Prices are currently fetching US$65/bbl, and...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has given back its morning gains and slipped into the red. At the time of writing, the benchmark index is down 0.2% to 8,789.6 points. Four ASX shares that are not letting that hold...

An ASX healthcare stock is back in focus today after a fresh update lifted confidence in its long-term outlook. The Neuren Pharmaceuticals Ltd (ASX: NEU) share price is up 7.77% to $20.80. Over the past year, the stock has climbed a...

Highlights Resource shares draw early attention Corporate updates influence sector movement Global trends shape local sentiment Australian equities opened cautiously as global cues remained mixed. Resource companies ga...

There are a lot of ASX growth shares out there for investors to choose from. To narrow things down, let's take a look at five that brokers rate as buys. Here's what you need to know about them: Aristocrat Leisure Ltd (ASX: ALL) Aristocrat...

The S&P/ASX 200 Index (ASX: XJO) produced a total return of 10.32% last year. That was comprised of 6.8% capital growth and 3.52% dividends. That dividend yield is below the benchmark index's historical average of 4.5% per annum s...

S&P/ASX 200 Index (ASX: XJO) shares rose by 6.8% and provided total gross returns, including dividends, of 10.32% in 2025. The benchmark index hit a record 9,115.2 points in October before finishing the year at 8,714.31 points. Th...

Betashares Australian Quality ETF (ASX: AQLT) has returned an average 12.5% per year to investors since its inception in April 2022. AQLT does things a little differently to standard index-tracking exchange-traded funds (ETFs). Inste...

In a tight race, drug developer Nyrada so far is this year’s star performer with almost an eightfold gain Diagnostic house Lumos and imagers Artrya and 4D Medical also have run a good race, with their US plans unfolding to script Nyrada ch...

Highlights Market sentiment remains cautious as sector leadership rotates Defensive assets attract attention amid uneven trading conditions Select ASX-listed names experience heightened activity Australian equities are...